Activate Your Research With CD45 Antibodies

July 16, 2015 - PRLog -- The Type I transmembrane protein CD45 is a protein tyrosine phosphatase that is used widely as a surface marker for nucleated hematopoietic cells. Due to its generally robust expression on cells of lymphoid and myeloid lineage, the presence or absence of CD45 is commonly assessed when characterizing mesenchymal stem cell populations. In addition, as a pivotal factor in the cell signaling network driving T cell development and immune cell activation threshold, CD45 is garnering much interest as both a potential immunomodulatory target as well as an interaction partner of certain viral proteins.

Synonyms: B220 antibody, CD45 antibody, CD45R antibody, GP180 antibody, LCA antibody, LY5 antibody, T200 antibody, PTPRC antibody, CD45 antigen antibody, receptor-type tyrosine-protein phosphatase C antibody, protein tyrosine phosphatase, receptor type, c polypeptide antibody, T200 leukocyte common antigen antibody, leukocyte common antigen antibody, leukocyte-common antigen antibody, T200 glycoprotein antibody, protein tyrosine phosphatase, receptor type, C antibody

See: CD45 antibody [GT0014] (GTX628507): http://www.genetex.com//CD45-antibody-GT0014-GTX628507.html